There are obvious similarities between McDonald’s (MCD) and Starbucks (SBUX). The global fast serve giants are ubiquitous from U.S. to China and nearly everywhere in between.
I’ve seen some articles comparing the two companies in terms of valuation metrics, dividends and potential growth. Which is the better buy? You can find out here and here if interested. However, I want to....More>>>
It is official: The Department of Labor’s (DOL) Fiduciary Rule is, slowly but surely, taking effect. As of June 9, 2017, all financial professionals who provide guidance on retirement plans are considered fiduciaries and must ensure they act in accordance with their clients’ best interests. The rule will impact the industry as a whole, but perhaps....More>>>
Over 150 years ago, Smith and Wesson designed bullet cartridges that bear the name of S&W and were manufactured and sold throughout the United States of America. Today, Smith and Wesson is one of the many companies of the new holding company, American Outdoor Brands Corporation (NASDAQ:AOBC). AOBC will serve as the foundation for S&W, along with many other brands, and....More>>>
401(k) Savers May Have to Fund Trumps Corporate Tax Cut
Texas Judge Denies Emergency Request to Block DOL Fiduciary Rule
Did Warren Overreach in Blasting Annuity Sales Perks?
R. Alexander Acosta, President Donald Trump’s nominee to be secretary of Labor, said Wednesday that if confirmed, he would follow the president’s Feb. 3 executive order directing Labor to review....More>>>
It would be fair to say biotech has had an interesting time of it over the course of the past 15 months. Except, of course, that biotech always has an interesting time of it. The go big or go home sector of the market attracts speculators, scientists, and unsavory characters, but also attracts people hoping for critical improvements to their healthcare options.
Welcome. In this article I will give the dollar and cents reasons for how come ERIC looks like a relative bargain in today’s marketplace.
In the trailing ten years ERIC has earned their market cap in free cash flow. This is a signal the company may be undervalued. If ERIC can repeat the performance and earn over $19B in the coming....More>>>
History could portend a bad omen for President-elect Donald Trump: recessions are more common under Republican presidents.
Every Republican president since Teddy Roosevelt in the early 1900’s endured a recession in their first term, according to an analysis from Sam Stovall, chief investment strategist atstock research firm CFRA.Four Republican presidents suffered through two recessions....More>>>
AMGN,AVEO,BGNE,BMY,CELG,Deals and Financings,FPRX,TCON,TRXC,VTVT,ZLAB,
Nanjing Legend Biotech received a $350 million upfront payment from Janssen Biotech, which will form a global partnership with Legend for its highly effective CAR-T candidate. In June, Legend, which was not previously well known, surprised the annual ASCO meeting with stunningly positive results
US based but China focused small cap biopharmaceutical stockCASI Pharmaceuticals (NASDAQ: CASI) is up around 78% over the last three trading days on no apparent news on the newswires as the following chart illustrates:
CASI Pharmaceuticals is a U.S. based, late-stage small cap biop
To begin this article, let's take a trip back to July 27th. AstraZeneca (NYSE:AZN) investors received the worst possible news with the news headline "AstraZeneca lung cancer immunotherapy trial failure sends shares plunging" effectively summing everything up. Shares absolutely